// App-Quantinova.ai

: Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma

Researchers

Presenter

  • Rahul Shrimanker

Principal Investigators

  • B Hargaden

  • P Bradding

  • AJ Wardlaw

  • CE Brightling

  • R Green

  • M Bafadhel

  • L Heaney

  • I Pavord

  • P Haldar

Medical Centers

  • University of Oxford, Oxford, United Kingdom

  • University of Leeds, Leeds, United Kingdom

  • Queen's University Belfast, Belfast, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • Prednisolone

  • Mepolizumab

Outcome

  • N/A


Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A